Also, have you explored R&D around adjuvants targeting mechanisms associated with resistance, eg—plasmid inhibitors (https://www.frontiersin.org/articles/10.3389/fmicb.2017.02329/full)
Also, have you explored R&D around adjuvants targeting mechanisms associated with resistance, eg—plasmid inhibitors (https://www.frontiersin.org/articles/10.3389/fmicb.2017.02329/full)